Compounds > droxidopa
Page last updated: 2024-08-26

droxidopa and Neuroleptic Malignant Syndrome

droxidopa has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, Y; Konagaya, M; Konishi, T; Matsuoka, Y1

Other Studies

1 other study(ies) available for droxidopa and Neuroleptic Malignant Syndrome

ArticleYear
[Malignant syndrome in multiple system atrophy].
    No to shinkei = Brain and nerve, 1997, Volume: 49, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Atrophy; Basal Ganglia Diseases; Corpus Striatum; Droxidopa; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Spinocerebellar Degenerations; Substantia Nigra

1997